Jenburkt Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 5 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ZAMRA (ZM) and CDSCO (India). Its GMP standing is certified by CDSCO (India). Customs aggregates show $2.6M of exports covering 267 molecules to 10 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Sihor, India | Not on file |
| bhavnagar, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ZAMRA (ZM) | 4 | None |
| CDSCO (India) | 1 | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $557K | 8 |
| 2025 | Not reported | $2.6M | 10 |
| 2024 | Not reported | $2.5M | 9 |
| 2023 | Not reported | $2.3M | 9 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Jenburkt Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free